Skip to Main Content

An official website of the United States government

View 0 Studies Requested

Trial Summary

About CDAS Project, PI, Publications: Insulin Resistance-Related Metabolic Markers and Pancreatic Cancer Risk

Datasets


Site: Pancreas

Inclusion Criteria:

  • No Prior History of Pancreatic Cancer
  • No Rare Cancers in Controls
  • T0 Serum Available
  • Not in Previous Biochem Study

Matching Factors:

  • Gender
  • Race
  • Age at Randomization (5 year intervals)
  • Year of Blood Draw
  • Month of Blood Draw (2 months)
  • Year of Birth (5 years)

Match Ratio: 2 to 1

Match Technique: Frequency matching only non-cases as controls.


Analytes:

  • Adiponectin
  • C-Peptide
  • Leptin
  • Transforming growth factor beta

Number of Cases: 120

Number of Controls: 120




Site: Pancreas

Inclusion Criteria:

  • No Prior History of Pancreatic Cancer
  • T0 Serum Available

Matching Factors:

  • Gender
  • Race
  • Age at Randomization (5 year intervals)
  • Year of Blood Draw
  • Month of Blood Draw (2 months)
  • Year of Birth (5 years)

Match Ratio: 2 to 1

Match Technique: Frequency matching with replacement and cases as controls (Incidence Density)


Analytes:

  • C-Peptide
  • C-Reactive Protein
  • Insulin-like Growth Factor 1
  • Insulin-like Growth Factor 2
  • Insulin-like Growth Factor Binding Protein 3
  • 25-Hydroxyvitamin D
  • Adiponectin
  • Cytotoxin-Associated Gene A
  • Helicobacter pylori
  • Leptin
  • Transforming Growth Factor Beta 1

Number of Cases: 187

Number of Controls: 382